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Solvates of the calcium-channel blocking agent felodipine with three structurally related common organic 
solvents, acetone (ATN), dimethyl sulfoxide (DMSO) and acetophenone (APN), are described. A 
relationship between the felodipine packing arrangement in all known solvates and the van der Waals 
volume of the solvent molecule is established. Intermolecular interaction energies in the crystals are 10 
examined using the PIXEL approach in order to rationalize the difference between alternative molecule 
packing arrangements. DSC studies show that the desolvation onset temperatures of the solvates are 
closely comparable, despite the large difference in the boiling points of the solvent molecules. The 
enthalpies of formation derived from the calorimetric data for the solvates are also found to be similar, 
despite the difference in the van der Waals volume of the solvent molecules. 15 
Introduction 
In many cases, active pharmaceutical ingredients (APIs) are 
established to exist in different crystal forms such as polymorphs 
or solvates/hydrates.1 The latter in general play a significant part 
in drug development, and solid-form screening to identify 20 
solvates/hydrates is a crucial prerequisite for consistent 
manufacturing and processing of drugs.2 Accidental solvate 
formation is highly undesirable during processing of drugs due to 
lack of predictability and, as a consequence, potentially 
uncontrollable changes of the physicochemical properties of a 25 
product. On the other hand, solvates of APIs with 
pharmaceutically relevant solvents can improve some 
physicochemical properties of drugs, such as solubility and 
dissolution rate.3 Moreover, desolvation of solvates can be a 
method to discover and prepare new polymorphic forms that may 30 
be inaccessible via ordinary crystallization techniques.4  
In this paper, we focus on studying the structures and 
physicochemical properties of solvates of the API felodipine with 
three structurally related common organic solvents, acetone 
(ATN), dimethyl sulfoxide (DMSO) and acetophenone (APN). 35 
Felodipine [systematic name: ethyl methyl 4-(2,3-
dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-
pyridinedicarboxylate] belongs to a family of dihydropyridine 
calcium channel blockers that are used for treatment of 
hypertension and regulation of arterial pressure (Fig. 1).5  40 
Four polymorphic forms of felodipine have been identified to 
date: forms I and II have been known for a long time,6 and we 
have quite recently reported forms III and IV.7 Polymorphism of 
felodipine co-crystals with 4,4′-bipyridine in 1:1 and 2:1 molar 
ratios has been studied,8 and a hydrated co-crystal of felodipine 45 
with diazabicyclo[2.2.2]octane (DABCO) has also been 
reported.9 In addition, felodipine exhibits a strong propensity for 
solvate formation with various solvents. The solvate of felodipine 
with acetone was described and characterized for the first time by 
Rollinger and Burger10 using DSC, IR spectroscopic and powder 50 
X-ray diffraction techniques. However, a single-crystal X-ray 
structure of the solvate has not previously been reported. The 
crystal structure of a felodipine solvate with formamide 
([Fel+FA]) has been published by Lou et al.,11 and two solvates 
with dimethylformamide (DMF) and N-methylformamide (N-55 
MeFA) have been studied by Perlovich et al.12  
We have also reported felodipine solvates with the structurally-
related high-boiling point solvents, dimethylacetamide (DMAA), 
dimethylethyleneurea (DMEU) and tetramethylurea (TMU).13 In 
this work, we consider all experimental data obtained so far in a 60 
systematic manner, with an aim to rationalize the relationships 
between the crystal structures of the solvates and their observed 
physicochemical properties, which is an important issue in a 
pharmaceutical solid-form development.  
 65 
Fig.1 Structure of felodipine and investigated solvent molecules with 
atom numbering.  
Page 1 of 9 CrystEngComm
C
ry
st
E
ng
C
om
m
A
cc
ep
te
d
M
an
us
cr
ip
t
 2  |  Journal Name, [year], [vol], 00–00 This journal is © The Royal Society of Chemistry [year] 
Material and Methods 
Compounds and solvents 
Felodipine (C18H19Cl2NO4, MW 384.26, 99.5%, racemate) was 
produced by Xiamen (Fine Chemical Import @ Export Co., LTD) 
and received as polymorphic form I. All solvents were purchased 5 
from Sigma-Aldrich (Denmark). All of the starting materials 
were used without further purification. 
Crystallization procedure 
The solvates of felodipine with dimethyl sulfoxide and 
acetophenone were prepared by dissolving felodipine in each 10 
respective solvent preheated to 60°C. The obtained clear solution 
was slowly cooled and then allowed to evaporate under ambient 
conditions. Single crystals of the felodipine solvate with acetone 
were obtained by slow evaporation of a saturated felodipine 
solution stored at -20°C in a freezer. Crystals obtained from the 15 
crystallization batches were air dried before being subjected to 
further analysis. 
X-ray diffraction 
Single-crystal X-ray diffraction data for [Fel+ATN] and 
[Fel+APN] were collected on a Bruker-Nonius X8-APEXII CCD 20 
diffractometer using MoKα radiation (λ = 0.7107 Å) at 150(1) K. 
Data for [Fel+DMSO] were collected under ambient conditions 
using a Bruker P4 diffractomer with MoKα radiation (λ = 0.7107 
Å). The structures were solved by direct methods and refined by 
full matrix least-squares on F2 with anisotropic thermal 25 
parameters for all non-hydrogen atoms. 
Aqueous dissolution measurements 
Dissolution measurements were carried out by the shake-flask 
method at 25.0 ± 0.1°C. Samples were suspended in 10 ml of 
water in glass tubes. The amount of felodipine solvate dissolved 30 
was measured by taking aliquots of 2 ml of the respective media 
and measuring concentration in a UV-vis spectrophotometer 
(Cary 50, Varian Inc.). The solid phase was removed by 
isothermal filtration (VWR syringe filter, PTFE, 0.45 µm). The 
results are stated as the average of at least three replicated 35 
experiments. 
Solution calorimetry 
Enthalpies of solution were measured by using an ampoule-type 
isoperibolic calorimeter with a titanium reaction vessel volume of 
50 cm3.14 The automated control scheme allowed the temperature 40 
to be maintained with an accuracy greater than 6 × 10–4 K. The 
temperature and thermal sensitivities of the calorimeter 
measuring cell were 10–4 K and 10–3 J, respectively. The 
instrumental errors were 0.6–1%. The accuracy of weight 
measurements corresponded to ±0.01 mg. Due to small values of 45 
the solution heat effects, a correction (q(T)) was introduced to 
account for the heat of breaking of the ampoule and evaporation 
of the solvent in the ampoule free volume: q(293.15 K) = 0.034 J, 
q(303.15 K) = –0.018 J, q(318.15 K) = –0.059 J. Other 
corrections were negligibly small. The calorimeter was calibrated 50 
using KCl (Merck analysis grade >99.5%) in water over a wide 
concentration interval with more than 20 measurements made. 
The obtained standard value of solution enthalpy was 17240 ± 36 
J⋅mol–1, which is in good agreement with the value 17241 ± 18 
J⋅mol–1 recommended by IUPAC.15 A minimum of four 55 
measurements were performed for each of the analyzed samples. 
Differential scanning calorimetry (DSC) 
Thermal analysis was carried out on a DSC 204 F1 Phoenix 
differential scanning heat ﬂux calorimeter (NETZSCH, Germany) 
with a high sensitivity µ-sensor. The sample was heated at a rate 60 
of 10°C⋅min-1 in an Ar atmosphere over the temperature range of 
25 to 170-180°C and cooled with gaseous N2. The temperature 
calibration was performed against six high-purity substances: 
cyclohexane (99.96%), Hg (99.99+%), biphenyl (99.5%), In 
(99.999%), Sn (99.999%), and Bi (99.9995%). The accuracy of 65 
the weighing procedure was ±0.01 mg. 
Thermogravimetric analysis (TGA) 
TGA was performed on a TG 209 F1 Iris thermomicrobalance 
(Netzsch, Germany). Approximately 10 mg of the sample was 
added to a platinum crucible. The samples were heated over the 70 
temperature range of 25 to 250°C at a constant heating rate of 
10°C·min-1. The samples were purged with a stream of flowing 
dry Ar throughout the experiment at 30 mL·min-1. 
Hot stage microscopy (HSM) 
Thermomicroscopic investigations were performed with an 75 
optical polarizing microscope (Altami Polar 312) equipped with a 
hot stage and Microstat 100 temperature controller. The 
microscope images were recorded with an Altami CMOS digital 
camera using Altami Studio image capture software. The samples 
were heated over a temperature range of 25–170°C at a constant 80 
heating rate of 2°C·min–1. The hot stage was calibrated using 
USP melting point standards (vanillin, acetanilide, phenacetin, 
caffeine). 
Computational procedures 
The van der Waals molecular volume (Vvdw) in the crystal lattice 85 
was calculated using the spatial descriptors in Materials Studio. 
Intermolecular interaction energies were analyzed using the 
PIXEL approach developed by Gavezzotti.16 This method 
provides quantitative determination of crystal lattice energies and 
pairwise intermolecular interactions, with a breakdown of these 90 
energies into coulombic, polarization, dispersion and repulsion 
terms. 
Results and Discussion 
Crystal structures 
Crystallographic data are summarized in Table 1, and the 95 
molecular units of the solvates are shown in Fig. 2. In each 
structure, the solvent molecule accepts an N–H···O hydrogen 
bond from the felodipine molecule. In the [Fel+DMSO] solvate, 
the S atom of the solvent molecule is disordered over two 
positions, with the major component having a site-occupancy 100 
factor of 0.857(6) (Fig.2a). The O atom (involved in the hydrogen 
bond) and the C atoms of the methyl group occupy consistent 
positions. This type of disorder is common in DMSO solvates. 
According to Cruz-Cabeza et al., almost 50% of DMSO solvate 
structures found in the Cambridge Structural Database show 105 
structural disorder.17 The ester groups of felodipine also show 
some disorder, corresponding to exchange of the positions of the 
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OMe and OEt groups.   
Table 1 Crystallographic data for [Fel+DMSO], [Fel+APN] and [Fel+ATN] 
Compound reference [Fel+DMSO] [Fel+APN] [Fel+ATN] 
Chemical formula C18H19Cl2NO4•C2H6OS C18H19Cl2NO4•C8H8O C18H19Cl2NO4•C3H6O 
Formula Mass 462.37 504.39 442.33 
Crystal system triclinic orthorhombic monoclinic 
a/Å 8.660(3) 7.3940(7) 9.1774(8) 
b/Å 9.816(3) 11.4991(10) 16.6983(15) 
c/Å 13.782(4) 29.003(2) 14.3375(11) 
α/° 87.37(2) 90 90 
β/° 79.17(3) 90 105.865(4) 
γ/° 77.79(3) 90 90 
Unit cell volume/Å3 1124.6(6) 2466.0(4) 2113.5(3) 
Temperature/K 293(2) 150(2) 150(2) 
Space group P–1 P212121 P21/n 
No. of formula units per unit cell, Z 2 4 4 
Calculated density, ρ/g cm–3  1.365 1.359 1.390 
Absorption coefficient, µ/mm-1 0.412 0.301 0.340 
No. of reflections measured 4671 11352 33416 
No. of independent reflections 3924 4368 4003 
Rint 0.042 0.036 0.046 
R1 (I > 2σ(I)) 0.084 0.053 0.040 
wR2 (all data) 0.242 0.119 0.086 
Goodness of fit on F2 1.04 1.07 1.04 
CCDC No. 1048182 1048181 1048180 
 
 5 
(a) 
 
(b) 
 
(c) 
 
Fig.2 Molecular units in (a) [Fel+DMSO] form I; (b) [Fel+APN]; (c) 
[Fel+ATN]. Displacement ellipsoids are shown at 50% probability. 
The same type of disorder is observed in the previously published 
[Fel+DMAA] and [Fel+DMEU] structures.  
The solvent molecule of [Fel+APN] is fully ordered and the 10 
plane of the APN molecule forms an angle of ca 12° with the 1,4-
dihydropyridine ring (Fig.2b). For the [Fel+ATN] solvate, the 
1,4-dihydropyridine ring of Fel and the plane of the hydrogen-
bonded ATN molecule form an angle of ca 9.4° (Fig. 2c).  
In our previous works, attention has been paid to the molecular 15 
conformation of felodipine in the known polymorphs, co-crystals 
and solvates.7,8,13 The molecular conformation of felodipine is 
essentially identical in [Fel+ATN] and [Fel+DMSO], and it 
corresponds to a relatively low-energy molecular conformer, 
which is observed in the most of the known felodipine solvates. 20 
In [Fel+APN], the OMe ester group adopts an opposite 
orientation, so that the C=O group points away from the Me 
group of the 1,4-dihydropyridine ring. This conformation is found 
to be similar to that in [Fel+TMU] and [Fel+FA] (see details in 
the Supporting Information). 25 
In the [Fel+DMSO] solvate, the Fel molecules are packed in a 
centrosymmetric “back-to-back” manner, which is one of the 
main structural features in the polymorphs of pure felodipine (see 
Figs. S2-S4 in the Supporting Information).7 The interplanar 
distance of 3.90 Å for these “back-to-back” contacts at the longer 30 
end of those observed in felodipine polymorphs I–IV (3.65–3.87 
Å). The packing arrangement of the [Fel+DMSO] solvate can be 
described as parallel layers of felodipine molecules (in the (01–1) 
planes), where the space between layers is occupied by DMSO 
(Fig 3a).  35 
In the [Fel+APN] solvate, the molecules are arranged as 
alternating bilayers of Fel and single layers of APN molecules 
parallel to the (001) planes. Thus, there are clear regions with the 
solvent-solvent interactions and regions where only felodipine 
molecules interact. At the inside of each Fel bilayer, the 40 
molecules are packed in a “side-on” manner so that the 
dichlorobenzene rings approach the backside of the neighbouring 
1,4-dihydropyridine rings. A similar packing arrangement is 
observed in the [Fel+TMU] solvate. In addition, C24-H24…O3 
Page 3 of 9 CrystEngComm
C
ry
st
E
ng
C
om
m
A
cc
ep
te
d
M
an
us
cr
ip
t
 4  |  Journal Name, [year], [vol], 00–00 This journal is © The Royal Society of Chemistry [year] 
interactions are formed between the phenyl ring of APN and the 
OMe group of Fel (Fig 3b).  
In the case of the [Fel+ATN] solvate, the structure does not show 
any clear separation of the Fel and solvent molecules, as 
observed for the [Fel+APN]. The hydrogen-bonded ATN 5 
molecules are situated between the neighboring Fel molecules 
forming a “face-to-face” contact with the dichlorobenzene rings 
(Fig 3c). The crystal structure of this solvate is also based on 
“back-to-back” interaction between Fel molecules, as observed 
for the [Fel+DMSO] solvate. However, every second 10 
centrosymmetric “back-to-back” molecular pair in [Fel+APN] is 
turned 90° to each other to form a ladder-type structure (Fig 3d). 
The perpendicular orientation of the neighbouring felodipine 
molecules leads to formation of C8-H8…O1 and C9-H9…O3 
interactions between dichlorobenzene rings and OMe/OEt 15 
groups. This type of packing arrangement is not observed in any 
of the other known felodipine polymorphs, solvates or co-
crystals. 
  
(a) (b) 
  
(c) (d) 
Fig.3 Molecular packing projections for (a) [Fel+DMSO]; (b) [Fel+APN]; (c), (d) [Fel+ATN] solvates. Solvent molecules are coloured in blue. H atoms 
are omitted. 20 
As mentioned in the Introduction, six solvates of felodipine are 
already reported in the literature. The crystal structures of the 
solvates (including the three new ones reported here) can be 
divided into two groups: those based on “back-to-back” packing 
arrangements of the Fel molecules and those where the units are 25 
packed in a “side-on” manner. Apparently, the Fel-Fel molecule 
arrangement should depend on the interaction energy between 
solvent and Fel as well as the spatial characteristics the solvent 
molecule that is present in the solvate structure. Different 
characteristics of the solvent molecules such as the ability to form 30 
donor-acceptor interactions and the topological similarity were 
tested in order to find a relationship between properties of the 
solvent and the crystal packing arrangement of the felodipine 
molecules (see details in the Supporting Information). The 
results, however, were not able to provide a clear answer to the 35 
question of interest. The most suitable parameter to consider is 
found to be the van der Waals volume (Vvdw) of the solvent 
molecule. Since all the solvent molecules have only one site of 
hydrogen bonding, this parameter is responsible for the most of 
the weak van der Waals interactions that occur between 40 
molecules in a crystal. 
Scheme 1 illustrates the change in the crystal packing 
arrangement as the van der Waals volume (Vvdw) of the solvent 
molecule increases.  
 45 
Scheme 1 The change in the crystal packing arrangement of the solvates 
with increasing van der Waals volume (Vvdw) of the solvent molecule 
It is evident that at relatively small Vvdw (40 Å
3 < Vvdw < 70 Å
3) 
the Fel molecules tend to form a “back-to-back” packing 
arrangement, which is also one of the main structural features in 50 
the crystals of the non-solvated compound. Formation of a “side-
on” organization is observed when the van der Waals volume of 
the solvent molecule is greater than 70Å3. In [Fel+DMF] and 
[Fel+DMAA], the neighboring Fel molecules are turned so that 
their dichlorobenzene rings lie approximately perpendicular to 55 
each other, while in [Fel+DMEU], the dichlorobenzene planes 
form an angle of ca 64°. Further increase of Vvdw of the solvent 
molecule over 110 Å3 also leads to modification of the packing 
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arrangement within the framework of a “side-on” crystal 
organization. In [Fel+APN] and [Fel+TMU], the Fel molecules 
are arranged into double layers of centrosymmetric units. Inside 
of each layer the molecules are related by crystallographic 
translation (along a). 5 
Thus, “side-on” and “back-to-back” structure organizations are 
two alternative packing arrangements for the Fel molecules in the 
solvates. It seems that the “side-on” interactions are less stable, 
since they are not seen in any of the polymorphs of pure 
felodipine. The stabilization of such structures is expected to be 10 
on account of differing intermolecular interactions with solvent 
molecules.  
In order to verify this assumption, the intermolecular interaction 
energies in the crystal structures were calculated using the PIXEL 
approach of Gavezzotti16 (Table 2). It is evident that dispersion 15 
interactions dominate the crystal structures of all of the solvates, 
while the Coulombic, polarization and repulsion terms play a 
lesser role. There are a few exceptions: for [Fel+FA] and [Fel+N-
MeFA], the contribution of the Coulombic interaction is slightly 
larger compared to that for the rest of the solvates due to extra 20 
hydrogen bonds formed between Fel and the solvent molecules. It 
should be noted that the crystal lattice energies (Elatt) for all of the 
solvates are closely comparable and independent of the packing 
arrangements. The average magnitude of Elatt for all of the 
crystals is found to be 111.4 kJ·mol-1, with a standard deviation 25 
of 5.2 kJ·mol-1 (4.7%).  
 
Table 2 The results of PIXEL calculations: lattice energies (Elatt), Coulombic energies (Ecoul), polarization energies (Epol), dispersion energies (Edisp) and 
repulsion (Erep) energies are in kJ·mol
-1 
 Ecoul Epol Edisp Erep Elatt 
[Fel+FA] -72.7 -27.2 -103.6 88.3 -115.1 
[Fel+N-MeFA] -62.4 -26.0 -109.4 81.5 -116.3 
[Fel+ATN] -48.2 -20.8 -123.1 88.7 -103.4 
[Fel+DMSO] -52.9 -29.8 -117.4 90.8 -109.4 
[Fel+DMF] -52.6 -24.3 -110.1 83.9 -103.1 
[Fel+DMAA] -56.7 -31.3 -128.5 108.5 -108.1 
[Fel+DMEU] -57.0 -27.7 -138.3 106.7 -116.3 
[Fel+APN] -52.1 -23.1 -135.3 95.0 -115.5 
[Fel+TMU] -53.0 -23.6 -123.9 84.9 -115.6 
 30 
Although the total crystal lattice energies are similar, the energy 
distribution between different types of molecules in the solvates 
is distinguishable (Fig. 4). It is evident that for the crystals with a 
“back-to-back” arrangement, the Fel-Fel interactions provide the 
largest contribution to the lattice energy, while the solvates with a 35 
“side-on” organization are mainly stabilized by Fel-Solv 
interactions, with the Fel-Fel term being less prominent. This 
supports the assumption made above that the structures based on 
“side-on” interactions are expected to be less stable with respect 
to their Fel-Fel interactions. The transformation from the “back-40 
to-back” to the “side-on” arrangement occurs at certain value of 
Vvdw for the solvent molecule, which is apparently large enough 
to stabilize the structure via more stabilizing Fel-Solv 
interactions. The overall similarity of the Elatt values indicates an 
effective distribution of all intermolecular interactions in the 45 
crystals so that the total lattice energies of the systems remain 
practically unchanged. 
 
Fig.4 The relative contributions of the intermolecular interaction energies 
between the different types of molecules in the solvates calculated using 50 
the PIXEL method 
As a next step, all of the solvate crystal structures were compared 
using the Crystal Packing Similarity module19 implemented in 
Mercury,20 in order to identify isostructural systems. For the 
“back-to-back” structures, the search did not reveal any similarity 55 
involving a statistically significant number of overlaid molecules 
(considered to be n > 10 and rmsdn < 1). However, comparison of 
the crystal structures of [Fel+DMF] and [Fel+DMAA], which 
are “side-on” arranged, indicates that these two crystals contain 
the same principal substructure of the Fel molecules (n = 20, 60 
rmsdn = 0.350 Å). (see Fig. S5 in the Supporting Information). 
For the rest of the “side-on” structures the search did not show 
any further satisfactory match. Thus, only two solvates are found 
to be isostructural. 
Thermal analysis 65 
In the present study, DSC, TGA and HSM were used to assess the 
stability of the [Fel+ATN], [Fel+APN] and [Fel+DMSO] solvate 
crystals. Detailed thermal analyses of the pure felodipine 
polymorphs and a number of different solvates have been 
reported previously.7, 12, 13 It has to be pointed out that the 70 
preparation and measurement procedures were unified for all the 
solvates in order to avoid the influence of those factors on the 
results of thermal analysis. The DSC curves are shown in Fig. 5, 
and the thermal data are tabulated in Table 3. For [Fel+APN] and 
[Fel+DMSO], DSC thermograms show only one endotherm 75 
which corresponds to the desolvation and melting processes. This 
thermal behaviour was found to be a common phenomenon for all 
of the felodipine solvates reported so far.12, 13 By contrast, 
[Fel+ATN] shows a broad desolvation peak over the range ~70-
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90°C, which is followed by melting of felodipine form I. The 
onset desolvation temperature is in good agreement with the data 
published by Rollinger and Burger.10 
Table 3 shows clearly that boiling points of the solvents are 
considerably higher than the temperatures of desolvation of the 5 
corresponding solvates. For [Fel+ATN], however, the boiling 
point of the solvent, which is significantly lower than that for 
other solvents, is found to be ca. 13.8°C lower than the 
desolvation temperature. In the solvates with high-boiling point 
liquids, the solvent does not evaporate completely as it is released 10 
from the crystal, and it partly dissolves the desolvated felodipine, 
as seen in HSM experiments (Figure S6-S8 in the Supporting 
Information). It should be noted that the mentioned processes can 
affect the desolvation enthalpies derived from the DSC 
experiment, so direct comparison of those would not be quite 15 
correct.  
Weight loss measurements in the TGA analysis are consistent 
with the DSC and HSM results (see Figure S9-S11 in the 
Supporting Information). The TGA curve for [Fel+ATN] 
indicates a classical one-step loss of solvent over the range ~70-20 
90°C, while for [Fel+APN] and [Fel+DMSO], a continuous 
weight loss is observed over a temperature range 80–250°C. The 
TGA data for the latter solvates show several consecutive 
processes taking place during heating. The first step corresponds 
to loss of solvent and solvent evaporation (80-230°C), while 25 
further heating leads to Fel decomposition (above 230°C). 
 
Fig.5 DSC curves of felodipine solvates and felodipine (form I) recorded 
at 10°C·min–1 heating rate 
Table 3 Thermophysical data for the felodipine solvates 30 
 Tdesolv, °C (onset) ∆Hdesolv, kJ mol
–1 Tboil, °C 
[Fel+ATN] 70.8 ± 0.4 46.0 ± 0.9 56.0 
[Fel+APN] 81.5 ± 0.5 47.4 ± 0.7 202.0 
[Fel+DMSO] 80.5 ± 0.5 41.4 ± 0.6 189.0 
[Fel+DMAA]a 110.6± 0.2 44.8 ± 0.5 165.1 
[Fel+DMEU]a 95.9 ± 0.2 34.4± 0.5 225.0 
[Fel+TMU]a 92.5 ± 0.2 31.0 ± 0.5 176.5 
[Fel+FA]b 122.7± 0.5 39.8 ± 0.9 210.0 
[Fel+N-Me-FA]b 84.8 ± 0.2 38.4 ± 0.4 182.6 
[Fel+DMF]b 82.1 ± 0.3 29.5 ± 0.3 153.0 
a Data taken from ref.13; 
b Data taken from ref.12 
Despite the large difference in the solvent boiling points, the 
desolvation onset temperatures of the solvates are closely 
comparable. Most of the systems lie in a narrow temperature 35 
range between 80 and 100°C. The [Fel+FA] and [Fel+DMAA] 
solvates show the highest thermal stability, whereas [Fel+ATN] 
is found to be the least thermally stable. 
It is evident that there is no correlation between the desolvation 
temperature of the solvates and the solvent boiling points. 40 
Usually thermal stability correlates with the boiling point of the 
solvent for solvates where the solvent molecules (guests) are 
weakly bound to the host molecules and situated in voids formed 
by the host structure.21 The PIXEL calculations for the Fel 
solvates reveal that the contributions to the lattice energy from 45 
the Fel-Fel and Fel-Solv interactions are comparable (Fig. 4). 
The Fel-Solv interactions comprise 35-44% in the crystals with a 
“back-to-back” packing arrangement and 45-53% in the solvates 
with a “side-on” organization. The solvate thermal stability 
depends on various factors such as the packing arrangement of 50 
felodipine and solvent molecules, the solvent accommodation in 
the structures as well as the desolvation mechanism of the 
solvate. For example, the difference in onset temperature between 
the [Fel+DMAA] and [Fel+DMF] isostructural solvates equals 
ca. 28.5°C, which is considerably larger than the average value 55 
for the structurally unrelated crystals. Similar results have 
recently been observed for phenobarbital solvates.22 
Solution calorimetry 
In order to establish the thermodynamic characteristics for 
formation of the felodipine solvates, and to estimate their 60 
thermodynamic stability, solution calorimetry experiments were 
carried out for felodipine in the respective solvents. For 
[Fel+ATN], solution calorimetry was not performed due to low 
stability of the solvate at room temperature and high volatility of 
acetone as a solvent, which can easily affect the experimental 65 
results. The results are summarized in Table 4 (see Table S1 in 
the Supporting Information for the full data set). 
Table 4 Solution enthalpies, ∆H°sol, and calculated enthalpies of 
formation, ∆H°f, at 298 K (kJ mol
–1) 
 ∆H°sol(Fel)Solv ∆H°sol([Fel+Solv])Solv ∆H°f([Fel+Solv]) 
[Fel+APN] 11.1 ± 0.2 27.1 ± 0.2 –16.0 ± 0.4 
[Fel+DMSO] 15.2 ± 0.1 30.8 ± 0.3 –15.6 ± 0.4 
[Fel+DMAA]a 10.9 ± 0.2 29.8 ± 0.3 –18.8 ± 0.5 
[Fel+DMEU]a 7.3 ± 0.2 25.9 ± 0.3 –18.6 ± 0.5 
[Fel+TMU]a 4.1 ± 0.1 23.0 ± 0.3 –18.9 ± 0.4 
a Data taken from ref.13. 70 
For all of the solvates, the enthalpies of formation derived from 
the calorimetric data are similar, despite the difference in the 
crystal packing arrangements. It should be noted that enthalpy of 
formation is an integral parameter which indicates the difference 
between the crystal lattice energy of a solvate and pure Fel. 75 
Therefore, it can be deduced that the solvates should have 
comparable Elatt values, which is consistent with the PIXEL 
calculations. 
Analysis of Hirshfeld Surfaces 
Analysis of Hirshfeld surfaces is found to be a useful tool for 80 
description of various types of intermolecular contacts in 
molecular crystals.23 The method has been widely used for 
polymorphs,24 solvates25 and co-crystals of APIs.26 The relative 
contributions of the important intermolecular contacts of Fel in 
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the solvates are compared to those of felodipine (Form I) in Fig.6. 
(The 2-D fingerprint plots for the solvates are shown in Fig. S12 
in the Supporting Information). 
For all of the solvates, the Н···Н contacts comprise 
approximately half of the total Hirshfeld surfaces (50.5 % in 5 
average), which indicates that the crystal structures are mainly 
stabilized by van der Waals interactions. A substantial part of 
each Hirshfeld surface is occupied by the C…H, O…H and 
Cl…H contacts. Their relative contributions to the Hirshfeld 
surfaces are comparable, comprising on average 14.9% for C…H, 10 
16.0% for O…H and 14.4% for Cl…H. The O…H contacts are 
the shortest ones in all of the solvates. It was noted that a ratio of 
the relative contributions of the main intermolecular contacts in 
the solvates remains practically unchanged: 
Н…Н/C…H/O…H/Cl…H ≈ 1/0.3/0.3/0.3. It might be reasonable 15 
to assume that this ratio indicates the most efficient crystal 
packing. 
 
Fig.6 The relative contribution of the intermolecular contacts to the 
Hirshfeld surface area for Fel in the solvates 20 
For pure felodipine form I, the contribution of the Н···Н contacts 
remains at the same level, comprising essentially half of the total 
surface. The O…H and Cl…H contacts also demonstrate similar 
contributions. A significant difference is observed for the C···H 
interactions, whose contribution is lower by approximately 40% 25 
in Fel compared to the average value in the solvates. 
 
Aqueous dissolution 
Dissolution profiles for [Fel+APN], [Fel+DMSO], the previously 
reported felodipine solvates and felodipine (form I) are shown in 30 
Fig. 7. For [Fel+ATN], the dissolution experiment was not 
performed due to its low stability at room temperature. It is seen 
that all of the dissolution profiles have a similar shape. In terms 
of the “spring and parachute” concept27 the dissolution profiles 
for the felodipine solvates show clearly a “spring” phase, while 35 
the “parachute” effect is observed only for a short time. During 
the first hour of dissolution, the concentration of felodipine is 
increased by several times compared to the form I of API. This is 
followed by fast crystallization of felodipine, and the latter 
process lasts from 1 to 6 hours depending on the solvate stability. 40 
The experiment shows that the least stable solvate is 
[Fel+DMSO], while the longest life-time is observed for 
[Fel+APN] and [Fel+TMU]. 
 
Fig.7 Dissolution profiles of the felodipine solvates and felodipine (form 45 
I) in water at 25.0 °C. 
 
Conclusions 
Three new solvates of felodipine with structurally related 
common organic solvents, acetone, dimethyl sulfoxide and 50 
acetophenone, have been obtained and their crystal structures 
determined. All of the currently established solvate crystal 
structures can be conventionally divided into two groups with 
respect to the felodipine packing arrangement: structures based 
on “back-to-back” interactions between felodipine molecules and 55 
crystals where the molecules are arranged in a “side-on” manner. 
The felodipine packing arrangement is found to depend on the 
van der Waals volume (Vvdw) of the solvent molecule. At 
relatively small Vvdw (40 Å
3 < Vvdw < 70 Å
3) the felodipine 
molecules tend to form a “back-to-back” structure, while 60 
formation of the “side-on” structure is observed for Vvdw > 70 Å
3. 
PIXEL calculations reveal that in the crystals with a “back-to-
back” arrangement, the Fel-Fel interactions provide the largest 
contribution to the lattice energy, while the solvates with a “side-
on” organization are mainly stabilized by Fel-Solv interactions, 65 
with the Fel-Fel contribution being less prominent. DSC studies 
show that the desolvation onset temperatures of the solvates are 
closely comparable, despite quite large differences in the solvent 
boiling points. For most of the systems, the desolvation occurs in 
a narrow temperature range between 80 and 100°C. The 70 
enthalpies of formation derived from the calorimetric data for the 
solvates are found to be similar, despite the difference in Vvdw of 
the solvent molecules. Analysis of Hirshfeld surfaces indicates 
that there is no significant difference in the distribution of the 
main intermolecular contacts between the solvates, and the 75 
following ratio is suggested: Н…Н/C…H/O…H/Cl…H ≈ 
1/0.3/0.3/0.3. The aqueous dissolution profiles for all solvates 
demonstrate only a clear “spring” phase, while the “parachute” 
effect is observed over a time period from 1 to 6 hours depending 
on the solvate stability. 80 
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Diversity of felodipine solvates: structure and physicochemical properties 
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Solvates of the calcium-channel blocking agent felodipine with three structurally related 
common organic solvents, acetone (ATN), dimethyl sulfoxide (DMSO) and acetophenone 
(APN), are described. A relationship between the felodipine packing arrangement in all known 
solvates and the van der Waals volume of the solvent molecule is established. The solvates were 
investigated by a wide spectrum of experimental methods and approaches: X-ray diffraction, 
DSC, TG, HSM and solution calorimetry. Intermolecular interaction energies in the crystals are 
examined using the PIXEL approach in order to rationalize the difference between alternative 
molecule packing arrangements. 
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